Galderma, the listed Swiss dermatology specialist, is acquiring the US skincare provider ZO Skin Health for 1.5 billion US dollars. The Californian company, founded by dermatologist Zein Obagi, offers more than 40 professional products, which are distributed in over 40 countries via doctors’ practices, medical spas and online retailers. The acquisition, which is being financed in cash, is expected to be completed this winter, subject to regulatory approvals, Galderma announced. With ZO Skin Health, the company aims to expand its skincare business, which includes major brands such as Cetaphil and Alastin, and to strengthen its position in professional skincare. Founded in 1981, Galderma generated global turnover of around US$5.2 billion last year with products for skincare, aesthetic medicine and therapeutic dermatology. Further information …